Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01773681 · ClinicalTrials.gov registry record
Novel Imaging Markers for Rheumatoid Arthritis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 30
- Enrollment target
NCT01773681 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants.
The verdict
NCT01773681 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to use magnetic resonance imaging (MRI) and high-resolution peripheral quantitative computed tomography (HR-pQCT) techniques to look at the damage and disease activity progression in the hand and wrist joints of patients with rheumatoid arthritis. The central hypothesis is that ongoing erosions and cartilage loss in rheumatoid arthritis are due to persistent inflammation, which is poorly detected by clinical examination and markers of systemic inflammation.
Interventions
- DEVICE Magnetic Resonance Imaging (MRI)
- DRUG Cimzia
- DEVICE High-resolution peripheral quantitative computed tomography (HR-pQCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01773681
The ClinicalTrials.gov registry entry for NCT01773681 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT01773681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01773681 about?
NCT01773681 is a clinical study titled "Novel Imaging Markers for Rheumatoid Arthritis". The purpose of this study is to use magnetic resonance imaging (MRI) and high-resolution peripheral quantitative computed tomography (HR-pQCT) techniques to look at the damage and disease activity progression in the hand and wrist joints of patients with rheumatoid arthritis. The central hypothesis...
What is the current status of trial NCT01773681?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-10. Estimated completion is 2018-03.
What interventions are being tested in trial NCT01773681?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DEVICE), Cimzia (DRUG), High-resolution peripheral quantitative computed tomography (HR-pQCT) (DEVICE).
Who is sponsoring clinical trial NCT01773681?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.